You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

17-025

Showing 1 - 25 of 4,748
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Beige Fat, Energy, and the Natriuretic Peptide System

Recruiting
  • Obesity
    • Nashville, Tennessee
    • +1 more
    Jul 1, 2022

    Healthy Trial in Taipei (FP-025, Placebo)

    Completed
    • Healthy
    • Taipei, Taiwan
      Taipei Veterans General Hospital
    Aug 4, 2022

    Short Bowel Syndrome Trial in Worldwide (Teduglutide 0.05mg/kg, Teduglutide 0.025 mg/kg, Standard of Care)

    Completed
    Has Results
    • Short Bowel Syndrome
    • Teduglutide 0.05mg/kg
    • +2 more
    • Los Angeles, California
    • +26 more
    May 14, 2021

    SARS-CoV-2 Infection, COVID-19 Trial in United Kingdom (SARS-CoV-2 rS/Matrix M1-Adjuvant, Placebo, Licensed seasonal influenza

    Active, not recruiting
    • SARS-CoV-2 Infection
    • COVID-19
    • SARS-CoV-2 rS/Matrix M1-Adjuvant
    • +2 more
    • Belfast, Antrim, United Kingdom
    • +32 more
    Oct 19, 2022

    Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

    Not yet recruiting
    • Melanoma
    • +16 more
    • Darlinghurst, New South Wales, Australia
    • +3 more
    May 12, 2023

    Generalized Myasthenia Gravis Trial in Worldwide (ARGX-113)

    Completed
    • Generalized Myasthenia Gravis
    • ARGX-113
    • Carlsbad, California
    • +51 more
    Jul 8, 2022

    Generalized Myasthenia Gravis Trial in Worldwide (efgartigimod PH20 SC)

    Active, not recruiting
    • Generalized Myasthenia Gravis
    • efgartigimod PH20 SC
    • Carlsbad, California
    • +46 more
    Jul 5, 2022

    Generalized Myasthenia Gravis Trial in Worldwide (efgartigimod PH20 SC, efgartigimod IV)

    Completed
    • Generalized Myasthenia Gravis
    • efgartigimod PH20 SC
    • efgartigimod IV
    • Carlsbad, California
    • +46 more
    Jan 31, 2022

    Generalized Myasthenia Gravis Trial in Worldwide (ARGX-113, Placebo)

    Completed
    Has Results
    • Generalized Myasthenia Gravis
    • ARGX-113
    • Placebo
    • Phoenix, Arizona
    • +65 more
    Jan 14, 2022

    Migraine Disorders Trial (Rizatriptan 5 mg, Rizatriptan 10 mg, Standard Care)

    Completed
    Has Results
    • Migraine Disorders
    • Rizatriptan 5 mg
    • +2 more
    • (no location specified)
    Feb 1, 2022

    Migraine Headache Trial (rizatriptan benzoate, Comparator: Placebo)

    Completed
    Has Results
    • Migraine Headache
    • rizatriptan benzoate
    • Comparator: Placebo
    • (no location specified)
    Feb 1, 2022

    Tuberculosis Trial in Chendu (BCG vaccine 1(0.025mg/0.1ml/person), BCG vaccine 2 (0.05mg/0.1ml/person), BCG vaccine

    Recruiting
    • Tuberculosis
    • BCG vaccine 1（0.025mg/0.1ml/person）
    • +4 more
    • Chendu, Sichuan, China
      Sichuan Center for Disease Control and Prevention
    Sep 1, 2022

    Multiple Myeloma Trial in New York (EGFRt/BCMA-41BBz CAR T cell, Cyclophosphamide, Lenalidomide.)

    Active, not recruiting
    • Multiple Myeloma
    • EGFRt/BCMA-41BBz CAR T cell
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 7, 2022

    Severe to Critical COVID 19 With Associated ARDS Trial in United States (FP-025 100 mg, FP-025 300 mg, Placebo)

    Terminated
    • Severe to Critical COVID 19 With Associated ARDS
    • FP-025 100 mg
    • +2 more
    • Chula Vista, California
    • +7 more
    Aug 4, 2022

    IBD, Dietary Exposure Trial in Groningen (Chicory Fiber)

    Not yet recruiting
    • Inflammatory Bowel Diseases
    • Dietary Exposure
    • Chicory Fiber
    • Groningen, Netherlands
      University Medical Center Groningen
    Aug 25, 2023

    HER2-positive Breast Cancer Trial in Nanjing (Pyrotinib)

    Recruiting
    • HER2-positive Breast Cancer
    • Nanjing, Jiangsu, China
      JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
    Apr 26, 2023

    Healthy, Drug-Drug Interaction Trial in Shanghai (JMKX000623, Metformin)

    Active, not recruiting
    • Healthy
    • Drug-Drug Interaction
    • Shanghai, Shanghai, China
      Huashan Hospital Fudan University
    Sep 30, 2023

    Myasthenia Gravis Trial in Worldwide (Nipocalimab, Placebo)

    Recruiting
    • Myasthenia Gravis
    • Mobile, Alabama
    • +134 more
    Aug 19, 2022

    Primary Dysmenorrhea Trial in Sialkot (Stretching Exercises, Dynamic core stabilizing exercises)

    Recruiting
    • Primary Dysmenorrhea
    • Stretching Exercises
    • Dynamic core stabilizing exercises
    • Sialkot, Punjab, Pakistan
      University of Sialkot
    Mar 15, 2023

    HER2-positive Breast Cancer Trial in Uppsala (ABY-PET)

    Recruiting
    • HER2-positive Breast Cancer
    • ABY-PET
    • Uppsala, Sweden
      Section for Clinical Research & Development Unit
    Sep 28, 2021

    Systemic Sclerosis Trial (RY_SW01 cell injection, Basic treatment)

    Not yet recruiting
    • Systemic Sclerosis
    • RY_SW01 cell injection
    • Basic treatment
    • (no location specified)
    Sep 21, 2023

    Esophageal Tumors, Gastric Tumors Malignant, Breast Cancer Trial in Stockholm ([68Ga]Ga-ABY-025 PET, Biopsy and analysis of HER2

    Recruiting
    • Esophageal Neoplasms
    • +3 more
    • [68Ga]Ga-ABY-025 PET
    • Biopsy and analysis of HER2 expression
    • Stockholm, Sweden
      Department of Radiation Physics and Nuclear Medicine, Karolinska
    Nov 25, 2022

    Drug-drug Interaction, Autoimmune Diseases, Fibrotic Disease Trial in Ruddington (Belumosudil, Itraconazole, Rabeprazole)

    Completed
    Has Results
    • Drug-drug Interaction
    • +2 more
    • Ruddington, Nottingham, United Kingdom
      Quotient Sciences Ltd
    May 9, 2022

    Allergic Rhinitis Trial in Lublin (Ismigen, Placebo)

    Completed
    • Allergic Rhinitis
    • Lublin, Poland
      Department of Pulmonary Diseases and Children Rheumatology, Medi
    Apr 2, 2022

    Volume Guided Management in Acute Kidney Injury Patients

    Not yet recruiting
    • Acute Kidney Injury
    • IVC ultrasound & Carotid doppler
    • (no location specified)
    Jul 9, 2023